Abbott will acquire AMO, a leader in ophthalmic care, for $22 per share in cash, for a total transaction value of approximately $2.8 billion.
"Through superior vision care technologies and service, AMO has established itself as a leader in this multi-billion dollar medical device segment," said Miles White, chairman and CEO of Abbott in the press release. "With AMO, Abbott is enhancing and strengthening its diverse mix of medical device businesses and gaining a leadership position in another large and growing segment."
Read the press release about the Abbott acquisition of AMO.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
